The central role of psychopathology and its association with disease severity in inflammatory bowel disease and irritable bowel syndrome

被引:1
作者
Piacentino, Daria [1 ,2 ,3 ]
Cesarini, Monica [4 ]
Badiali, Danilo [4 ]
Pallotta, Nadia [4 ]
Biondi, Massimo [5 ]
Corazziari, Enrico Stefano [4 ,6 ]
机构
[1] Sapienza Univ Rome, St Andrea Hosp, NESMOS Neurosci Mental Hlth & Sensory Organs Dept, Rome, Italy
[2] NIAAA, Sect Clin Psychoneuroendocrinol & Neuropsychophar, DICBR, Bethesda, MD 20892 USA
[3] NIDA, IRP, NIH, Bethesda, MD 20892 USA
[4] Sapienza Univ Rome, Dept Internal Med & Med Specialties, Policlin Umberto I, Rome, Italy
[5] Sapienza Univ Rome, Dept Human Neurosci, Policlin Umberto I, Rome, Italy
[6] Humanitas Clin Inst, Dept Gastroenterol, Milan, Italy
关键词
Inflammatory bowel disease; irritable bowel syndrome; psychopathology; Symptom Checklist-90-Revised; disease severity; QUALITY-OF-LIFE; PSYCHOLOGICAL DISTRESS; CROHNS-DISEASE; PSYCHIATRIC-ILLNESS; ULCERATIVE-COLITIS; SWEDISH PATIENTS; ANXIETY; DEPRESSION; IMPACT; IBS;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background. Biopsychosocial models for both organic and functional gastrointestinal (GI) disorders can be found in the literature. To clarify the role of psychopathological factors and their relationship with GI symptom severity, several studies have examined them in inflammatory bowel disease (IBD) - occasionally distinguishing between ulcerative colitis (UC) and Crohn's disease (CD) - and in irritable bowel syndrome (IBS), leading to unclear results. Aims. We aimed to evaluate the psychopathological features of IBD and IBS patients in comparison with healthy individuals and assess the association with disease severity. Materials and methods. Sixty-nine IBD outpatients, of which 35 UC and 34 CD, and 75 IBS ones were consecutively recruited at the third level Gastroenterological Center of our University Hospital; 76 healthy controls were also recruited. The psychological status was assessed with the Symptom Checklist-90-Revised (SCL-90-R). Results. IBD and IBS patients showed significantly higher scores on the SCL-90-R Global Severity Index (GSI) and subscales than controls (all p-values<0.001), and IBS patients showed significantly higher GSI, depression, and anxiety scores than IBD patients (all p-values<0.01). Psychopathology was comparable between UC and CD patients. In IBD and IBS patients the SCL-90-R GSI was significantly associated with disease severity (p<0.001). Conclusions. The presence of chronic bowel symptoms, either organic or functional, is linked to a greater severity of psychopathology compared to the general population, possibly as a consequence of higher loads of stress due to the symptoms affecting everyday life. In both IBD and IBS patients, greater disease severity and worse psychopathological functioning are related.
引用
收藏
页码:75 / 83
页数:9
相关论文
共 50 条
  • [21] The Dilemma of Persistent Irritable Bowel Syndrome Symptoms in Patients with Quiescent Inflammatory Bowel Disease
    de Arce, Edith Perez
    Quera, Rodrigo
    Quigley, Eamonn M. M.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2021, 50 (03) : 689 - 711
  • [22] A Comparative Study of Quality of Life in Persons With Irritable Bowel Syndrome and Inflammatory Bowel Disease
    Blagden, Sarah
    Kingstone, Thomas
    Soundy, Andrew
    Lee, Rhonda
    Singh, Sukhdev
    Roberts, Lesley
    GASTROENTEROLOGY NURSING, 2015, 38 (04) : 268 - 278
  • [23] Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?
    Quigley, Eamonn M. M.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2016, 9 (02): : 199 - 212
  • [24] Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease
    Whelan, Kevin
    Quigley, Eamonn M. M.
    CURRENT OPINION IN GASTROENTEROLOGY, 2013, 29 (02) : 184 - 189
  • [25] Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management
    Ledergerber, Martina
    Lang, Brian M.
    Heinrich, Henriette
    Biedermann, Luc
    Begre, Stefan
    Zeitz, Jonas
    Krupka, Niklas
    Rickenbacher, Andreas
    Turina, Matthias
    Greuter, Thomas
    Schreiner, Philipp
    Roth, Rene
    Siebenhuner, Alexander
    Vavricka, Stephan R.
    Rogler, Gerhard
    Beerenwinkel, Niko
    Misselwitz, Benjamin
    BMC GASTROENTEROLOGY, 2021, 21 (01)
  • [26] Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
    Lo Presti, Alessandra
    Zorzi, Francesca
    Del Chierico, Federica
    Altomare, Annamaria
    Cocca, Silvia
    Avola, Alessandra
    De Biasio, Fabiola
    Russo, Alessandra
    Cella, Eleonora
    Reddel, Sofia
    Calabrese, Emma
    Biancone, Livia
    Monteleone, Giovanni
    Cicala, Michele
    Angeletti, Silvia
    Ciccozzi, Massimo
    Putignani, Lorenza
    Guarino, Michele Pier Luca
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [27] Experiences of healing therapy in patients with irritable bowel syndrome and inflammatory bowel disease
    Andrew Soundy
    Rhonda T Lee
    Tom Kingstone
    Sukhdev Singh
    Pankaj R Shah
    Lesley Roberts
    BMC Complementary and Alternative Medicine, 15
  • [28] Are probiotics or prebiotics useful in pediatric irritable bowel syndrome or inflammatory bowel disease?
    Guandalini, Stefano
    FRONTIERS IN MEDICINE, 2014, 1
  • [29] Useful Tools to Differentiate Irritable Bowel Syndrome from Inflammatory Bowel Disease
    Goldis, Adrian
    Goldis, Ramona
    Lazar, Daniela
    NEUROGASTRO 2017 - MEETING OF THE ROMANIAN SOCIETY OF NEUROGASTROENTEROLOGY WITH ROME IV REGIONAL CENTRAL EAST EUROPEAN MEETING, 2017, : 92 - 98
  • [30] Perceptions of illness stigma in patients with inflammatory bowel disease and irritable bowel syndrome
    Taft, Tiffany H.
    Keefer, Laurie
    Artz, Caroline
    Bratten, Jason
    Jones, Michael P.
    QUALITY OF LIFE RESEARCH, 2011, 20 (09) : 1391 - 1399